Abstract
Vulvar pain is an enigma. Its etiology, pathophysiology, and treatment have not yet been elucidated. The most perplexing presentation is pain during intercourse, sometimes prevents the possibility to have intercourse. Around the enigma of vulvar pain, myths about its causes and treatments emerged. This chapter breaks these myths. The 2015 consensus terminology has changed the management paradigm of vulvar pain: now evaluation should be made according to the associated factor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bornstein J, Goldstein AT, Stockdale CK, Bergeron S, Pukall C, Zolnoun D, Coady D. 2015 ISSVD, ISSWSH, and IPPS consensus terminology and classification of persistent vulvar pain and vulvodynia. J Low Genit Tract Dis. 2016;20:126–30.
Bogliatto F, Miletta M. Vulvodynia: when a paradigm challenges the management. J Low Genit Tract Dis. 2017;21:85–6.
McKay M. Dysesthetic (“essential”) vulvodynia: treatment with amitriptyline. J Reprod Med. 1993;38:9–13.
Bornstein J, Maman M, Abramovici H. Primary versus secondary vestibulitis - one disease, two variants. Am J Obstet Gynecol. 2001;184:28–31.
Sutton K, Pukall C, Chamberlain S. Pain, psychosocial, sexual, and psychophysical characteristics of women with primary vs. secondary provoked vestibulodynia. J Sex Med. 2009;6:205.
van Lankveld JJDM, Granot M, Weijmar Schultz WCM, et al. Women’s sexual pain disorders. J Sex Med. 2010;7:615.
Reed BD, Harlow SD, Sen A, et al. Prevalence and demographic characteristics of vulvodynia in a population-based sample. Am J Obstet Gynecol. 2012;206:170.e1.
Reed BD, Haefner HK, Sen A, et al. Vulvodynia incidence and remission rates among adult women: a 2-year follow-up study. Obstet Gynecol. 2008;112:231.
Reed BD, Crawford S, Couper M, et al. Pain at the vulvar vestibule: a web-based survey. J Low Genit Tract Dis. 2004;8:48.
Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc. 2003;58:82.
Arnold LD, Bachmann GA, Rosen R, et al. Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. Am J Obstet Gynecol. 2007;196:128.e1.
Harlow B, Kunitz C, Nguyen R, et al. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions. Am J Obstet Gynecol. 2014;210:40.e1.
Turk DC, Galer BS, Hewitt DJ, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003;106:337–45.
Friedrich EG. Vulvar vestibulitis syndrome. J Reprod Med. 1987;32:110.
Goldfinger C, Pukall CF, Gentilcore-Saulnier E, et al. A prospective study of the effectiveness of pelvic floor physical therapy: pain and psychosexual outcomes in provoked vestibulodynia. J Sex Med. 2009;6:1955–68.
King M, Rubin R, Goldstein AT. Current uses of surgery in the treatment of genital pain. Curr Sex Health Rep. 2014;6:252.
Pukall CF, Binik YM, Khalifé S. A new instrument for pain assessment in vulvar vestibulitis syndrome. J Sex Marital Ther. 2004;30:69.
Pukall CF, Binik YM, Khalifé S, et al. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain. 2002;96:163.
Marinoff SC, Turner ML. Vulvar vestibulitis syndrome. Dermatol Clin. 1992;10:435–44.
Foster D, Kotok M, Huang L, et al. The tampon test for vulvodynia treatment outcomes research reliability, construct validity, and responsiveness. Obstet Gynecol. 2009;113:825–32.
Reed BD, Harlow SD, Plegue MA, Sen A. Remission, relapse, and persistence of vulvodynia: a longitudinal population-based study. J Womens Health (Larchmt). 2016;25:276–83.
Reed BD, Plegue MA, Harlow SD, Haefner HK, Sen A. Does degree of vulvar sensitivity predict vulvodynia characteristics and prognosis? J Pain. 2017;18:113–23.
Smith EM, Ritchie JM, Galask R, Pugh EE, Jia J, Ricks-McGillan J. Case-control study of vulvar vestibulitis risk associated with genital infections. Infect Dis Obstet Gynecol. 2002;10(4):193–202.
Farmer MA, Taylor AM, Bailey AL, et al. Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Transl Med. 2011;3:101–91.
Foster DC, Falsetta ML, Woeller CF, et al. Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women. Pain. 2015;156:386–96.
Bornstein J, Livnat G, Stolar Z, Abramovici H. Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment. Gynecol Obstet Invest. 2000;50(3):194–7.
Arnold LD, Bachmann GA, Rosen R, et al. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol. 2006;107:617.
Marinoff SC, Turner ML. Hypersensitivity to vaginal candidiasis or treatment vehicles in the pathogenesis of minor vestibular gland syndrome. J Reprod Med. 1986;31(9):796–9.
Burrows LJ, Basha M, Goldstein AT. The effects of hormonal contraceptives on female sexuality: a review. J Sex Med. 2012;9:2213.
Bornstein J, Goldshmid N, Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest. 2004;58:171–8.
Bornstein J, Zarfati D, Sela S, Cohen Y, Ophir E. Involvement of heparanase in the pathogenesis of localized vulvodynia. Int J Gynecol Pathol. 2008;27(1):136–41.
Morin M, Bergeron S, Khalifé S, et al. Morphometry of the pelvic floor muscles in women with and without provoked vestibulodynia using 4D ultrasound. J Sex Med. 2014;11:776–85.
Westrom LV, Willen R. Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gynecol. 1998;91:572–6.
Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest. 1999;48:270–5.
Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Torebjörk E. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. Pain. 2001;94:177–83.
Leclair CM, Goetsch MF, Korcheva VB, et al. Differences in primary compared with secondary vestibulodynia in immunohistochemistry. Obstet Gynecol. 2011;117:1307.
Goetsch MF, Morgan TK, Korcheva VB, et al. Histologic and receptor analysis of primary and secondary Vestibulodynia and controls: a prospective study. Am J Obstet Gynecol. 2010;202:614.e1.
Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain. 2004;8(2):129–33.
Gerber S, Bongiovanni AM, Ledger WJ, et al. Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2002;186:696.
Pukall CF, Cahill CM. New developments in the pathophysiology of genital pain: the role of central sensitization. Curr Sex Health Rep. 2014;6:11.
Willis WD. Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci. 2001;933:142–56.
Pierce AN, Zhang Z, Fuentes IM, Wang R, Ryals JM, Christianson JA. Neonatal vaginal irritation results in long-term visceral and somatic hypersensitivity and increased hypothalamic-pituitary-adrenal axis output in female mice. Pain. 2015;156(10):2021–31.
Gerber S, Bongiovanni AM, Ledger WJ, et al. Interleukin-1b gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol. 2003;107:74.
Goldstein AT, Belkin ZR, Krapf JM, et al. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014;11:2764.
Babula O, Linhares IM, Bongiovanni AM, Ledger WJ, Witkin SS. Association between primary vulvar vestibulitis syndrome, defective induction of tumor necrosis factor-alpha, and carriage of the mannose-binding lectin codon 54 gene polymorphism. Am J Obstet Gynecol. 2008;198(1):101.e1–4.
Foster DC, Sazenski TM, Stodgell CJ. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med. 2004;49:503.
FitzGerald MP, Kotarinos R. Rehabilitation of the short pelvic floor. I: background and patient evaluation. Int Urogynecol J. 2003;14:261–8.
Reed B, Harlow S, Legocki L, et al. Oral contraceptive use and risk of vulvodynia: a population-based longitudinal study. BJOG. 2013;120:1678.
Foster DC, Woodruff JD. Case-control study of vulvar vestibulitis syndrome. J Womens Health. 1995;4:677.
Bazin S, Bouchard C, Brisson J, et al. Vulvar vestibulitis syndrome: an exploratory case-control study. Obstet Gynecol. 1994;83:47.
Bouchard C, Brisson J, Fortier M, et al. Use of oral contraceptive pills and vulvar vestibulitis: a case-control study. Am J Epidemiol. 2002;156:254.
Harlow BL, Vitonis AF, Stewart EG. Influence of oral contraceptive use on the risk of adult-onset vulvodynia. J Reprod Med. 2008;53:102.
Greenstein A, Ben-Aroya Z, Fass O, et al. Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills. J Sex Med. 2007;4:1679.
Burrows LJ, Goldstein AT. The treatment of Vestibulodynia with topical estradiol and testosterone. Sex Med. 2013;1:30.
Kingsberg S, Kellogg S, Krychman M. Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy. Int J Womens Health. 2010;1:105–11.
Harlow BL, He W, Nguyen RHN. Allergic reactions and risk of vulvodynia. Ann Epidemiol. 2009;19:771.
Chaim W, Meriwether C, Gonik B, et al. Vulvar vestibulitis subjects undergoing surgical intervention: a descriptive analysis and histopathological correlates. Eur J Obstet Gynecol. 1996;68:165.
Farajun Y, Zarfati D, Abramov L, Livoff A, Bornstein J. Enoxaparin treatment for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2012;120(3):565–72.
Kakurai M, Monteforte R, Suto H, Tsai M, Nakae S, Galli SJ. Mast cell-derived tumor necrosis factor can promote nerve fiber elongation in the skin during contact hypersensitivity in mice. Am J Pathol. 2006;169(5):1713–21.
Harlow B, Stewart E. Adult-onset vulvodynia in relation to childhood violence victimization. Am J Epidemiol. 2005;161:871.
Khandker M, Brady SS, Stewart EG, et al. Is chronic stress during childhood associated with adult-onset vulvodynia? J Womens Health. 2014;23:649.
Leclerc B, Bergeron S, Binik YM, et al. History of sexual and physical abuse in women with dyspareunia: association with pain, psychosocial adjustment, and sexual functioning. J Sex Med. 2010;7:971.
Ayling K, Ussher JM. “If sex hurts, am I still a woman?” The subjective experience of vulvodynia in hetero-sexual women. Arch Sex Behav. 2008;37:294.
Desrochers G, Bergeron S, Khalifé S, et al. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia. Clin J Pain. 2009;25:520–7.
Nguyen RHN, Turner RM, Rydell SA, et al. Perceived stereotyping and seeking care for chronic vulvar pain. Pain Med. 2013;14:1461.
Landry T, Bergeron S, Dupuis M, et al. The treatment of provoked vestibulodynia: a critical review. Clin J Pain. 2008;24:155–71.
Bornstein J, Abramovici H. Combination of sub-total perineoplasty and interferon for vulvar vestibulitis - a comparative study. Gynecol Obstet Invest. 1997;44:53–4.
Bornstein J, Goldik Z, Stolar Z, et al. Predicting the outcome of surgical treatment of vulvar vestibulitis. Obstet Gynecol. 1997;89:695–8.
Heddini U, Bohm-Starke N, Nilsson KW, et al. Provoked vestibulodynia—medical factors and comorbidity associated with treatment outcome. J Sex Med. 2012;9:1400–6.
Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage 1a expression and interleukin 1 production. J Immunol. 1982;129:1803–5.
Horowitz BJ. Interferon therapy for condylomatous vulvitis. Obstet Gynecol. 1989;73(3 Pt 1):446–8.
Kieseier BC. The mechanism of action of interferon-β in relapsing multiple sclerosis. CNS Drugs. 2011;25(6):491–502.
Foster DC, Hasday JD. Elevated tissue levels of interleukin-1b and tumor necrosis factor-a in vulvar vestibulitis. Obstet Gynecol. 1997;89:291–6.
Bornstein J, Pascal B, Abramovici H. Intramuscular beta interferon treatment for severe vulvar vestibulitis. J Reprod Med. 1993;38:117–20.
Bornstein J, Pascal B, Abramovici H. Long term follow up of patients treated for severe vulvar vestibulitis by intramuscular interferon beta administration. Isr J Obstet Gynecol. 1994;5:146–8.
Marinoff S, Turner M, Hirsch R, Richard G. Intralesional alpha interferon. Cost-effective therapy for vulvar vestibulitis syndrome. J Reprod Med. 1993;38:19–24.
Kent HL, Wisniewski PM. Interferon for vulvar vestibulitis. J Reprod Med. 1990;35:1138–40.
Nyirjesy P, Sobel JD, Weitz MV, et al. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo controlled study. Sex Transm Infect. 2001;77:53–7.
Crisp CC, Vaccaro CM, Estanol MV, Oakley SH, Kleeman SD, Fellner AN, Pauls RN. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J. 2013;24:1915–23.
Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107:125–33.
Petersen CD, Giraldi A, Lundvall L, Kristensen E. Botulinum toxin type A e a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med. 2009;6:2523–37.
Pelletier F, Parratte B, Penz S, et al. Efficacy of high doses of botulinum toxin A for treating provoked vestibulodynia. Br J Dermatol. 2011;164:617–22.
Dystra DD, Presthus J. Botulinum toxin type A for the treatment of provoked vestibulodynia: an open-label pilot study. J Reprod Med. 2006;51:467–70.
Romito S, Bottanelli M, Pellegrini M, et al. Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest. 2004;58:164–7.
Brown CS, Glazer HI, Vog V, Menkes D, Bachmann G. Subjective and objective outcomes of botulinum toxin type A treatment in vestibulodynia: pilot data. J Reprod Med. 2006;51:635–41.
Hartmann D, Strauhal MJ, Nelson CA. Treatment of women in the United States with localized, provoked vulvodynia: practice survey of women’s health physical therapists. J Reprod Med. 2007;52:48.
Vallinga MS, Spoelstra SK, Hemel IL, van de Wiel HB, Weijmar Schultz WC. Transcutaneous electrical nerve stimulation as an additional treatment for women suffering from therapy-resistant provoked vestibulodynia: a feasibility study. J Sex Med. 2015;12(1):228–37.
Murina F, Graziottin A, Felice R, Radici G, Tognocchi C. Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation. J Low Genit Tract Dis. 2013;17(2):111–6.
Cecilio SB, Zaghi S, Cecilio LB, Correa CF, Fregni F. Exploring a novel therapeutic approach with noninvasive cortical stimulation for vulvodynia. Am J Obstet Gynecol. 2008;199(6):e6–7.
Morin A, Léonard G, Gougeon V, Cyr MP, Waddell G, Bureau YA, Girard I, Morin M. Efficacy of transcranial direct-current stimulation in women with provoked vestibulodynia. Am J Obstet Gynecol. 2017;216(6):584.e1–584.e11.
Haefner HK, Collins ME, Davis GD, Edwards L, Foster DC, Hartmann ED, Kaufman RH, Lynch PJ, Margesson LJ, Moyal-Barracco M, Piper CK, Reed BD, Stewart EG, Wilkinson EJ. The vulvodynia guideline. J Low Genit Tract Dis. 2005;9(1):40–51.
Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102:84–7.
Goetsch MF, Lim JY, Caughey AB. Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial. Obstet Gynecol. 2014;123(6):1231–6.
Rapkin AJ, McDonald JS, Morgan M. Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2008;198(41):e1–5.
Foster DC, Kotok MB, Huang L, et al. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116:583–93.
Bornstein J, Tuma R, Farajun Y, Azran A, Zarfati D. Topical nifedipine for the treatment of localized provoked vulvodynia: a placebo-controlled study. J Pain. 2010;11(12):1403–9.
Goldstein AT, Pukall CF, Brown C, Bergeron S, Stein A, Kellogg-Spadt S. Vulvodynia: assessment and treatment. J Sex Med. 2016;13(4):572–90.
Stockdale CK, Lawson HW. 2013 vulvodynia guideline update. J Low Genit Tract Dis. 2014;18(2):93–100.
Danielsson I, Torstensson T, Brodda-Jansen G, et al. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand. 2006;85:1360–7.
Baron R. Capsaicin and nociception: from basic mechanism to novel drug. Lancet. 2000;356:785–6.
Andrews JC. Vulvodynia interventions--systematic review and evidence grading. Obstet Gynecol Surv. 2011;66(5):299–315.
Bornstein J, Zarfati D, Goldik Z, Abramovici H. Vulvar vestibulitis: physical or psychosexual problem. Obstet Gynecol. 1999;93:876–80.
Har-Toov J, Militscher I, Lessing JB, Abramov L, Chen J. Combined vulvar vestibulitis syndrome with vaginismus: which to treat first? J Sex Marital Ther. 2001;27:521–3.
Bornstein J, Zarfati D, Goldik Z, Abramovici H. Perineoplasty versus vestibuloplasty for severe vulvar vestibulitis: a randomized comparison. Br J Obstet Gynecol. 1995;102:652–5.
Bornstein J, Goldik Z, Stolar Z, Zarfati D, Abramovici H. Predicting the outcome of surgical treatment for vulvar vestibulitis. Obstet Gynecol. 1997;89:695–8.
Tommola P, Unkila-Kallio L, Paavonen J. Surgical treatment of vulvar vestibulitis: a review. Acta Obstet Gynecol Scand. 2010;89:1385–95.
Bergeron S, Khalifé S, Glazer HI, et al. Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome. Obstet Gynecol. 2008;111:159–66.
Woodruff JD, Parmley TH. Infection of the minor vestibular gland. Obstet Gynecol. 1983;62(5):609–12.
Burrows LJ, Sloane M, Davis G, Heller DS, Brooks J, Goldstein AT. Parturition after vestibulectomy. J Sex Med. 2011;8:303–5.
Corsini-Munt S, Bergeron S, Rosen NO, et al. Feasibility and preliminary effectiveness of a novel cognitive behavioral couple therapy for provoked vestibulodynia: a pilot study. J Sex Med. 2014;11:2515–27.
Wan EL, Goldstein AT, Tolson H, Dellon AL. Injury to perineal branch of pudendal nerve in women: outcome from resection of the perineal branches. J Reconstr Microsurg. 2017;33:395–401.
Bornstein J, Goldik Z, Alter Z, Zarfati D, Abramovici H. Persistent vulvar vestibulitis- the continuing challenge. Obstet Gynecol Surv. 1997;53:39–44.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Q-tip applicator test for diagnosis of LPV (MPG 12707 kb)
Vestibulectomy (MPG 148042 kb)
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bornstein, J. (2019). Vulvar Pain and Vulvodynia. In: Bornstein, J. (eds) Vulvar Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-61621-6_54
Download citation
DOI: https://doi.org/10.1007/978-3-319-61621-6_54
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61620-9
Online ISBN: 978-3-319-61621-6
eBook Packages: MedicineMedicine (R0)